Evidence map›Paper›PMID 41133939›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Subventricular Zone-on-a-Chip: A Model to Study Neurogenesis Disruption in Neonatal Intraventricular Hemorrhage.

Laura Nicoleti Zamproni, Begüm Gökçe, Magnus Gram, Coco Holliday, Aylin Sendemir, Marimélia Aparecida Porcionatto, Anna Herland

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura Nicoleti ZamproniDepartment of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, 04044-020, Brazil.
Begüm GökçeAIMES - Center for the Advancement of Integrated Medical and Engineering Sciences at Karolinska Institutet and KTH Royal Institute of Technology, Stockholm, 17164, Sweden.
Magnus GramPediatrics, Department of Clinical Sciences Lund, Lund University, Lund, 22184, Sweden.
Coco HollidayDepartment of Immunology, Harvard Medical School, Boston, MA, 02115, USA.
Aylin SendemirDepartment of Bioengineering, Faculty of Engineering, Ege University, Izmir, 35040, Türkiye.
Marimélia Aparecida PorcionattoDepartment of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, 04044-020, Brazil.
Anna HerlandDivision of Nanobiotechnology, SciLifeLab, Department of Protein Science, KTH Royal Institute of Technology, Solna, 17165, Sweden.ORCID https://orcid.org/0000-0002-5002-2537

Funding

Crafoord FoundationInternational Research Fellowship ProgrammeNational Council for Scientific and Technological Development (CNPq) 202 895/2019-0National Council for Scientific and Technological Development (CNPq) TUBITAK 2214-ASão Paulo Research Foundation (FAPESP) 2021/14327-8São Paulo Research Foundation (FAPESP) 2022/16296-5
6 · The paper itself

Abstract

Intraventricular hemorrhage (IVH) in preterm infants disrupts neurogenesis in the subventricular zone (SVZ), a key neurogenic niche, yet no effective treatments exist. This work develops a human SVZ-on-a-chip model to investigate the inflammatory response in IVH and its impact on neurogenesis. Using this platform, this work examines the effects of red blood cell lysate (RBCL) and hemorrhagic cerebrospinal fluid (CSF) from preterm infants with IVH on SVZ cells. Transcriptomic analysis reveal activation of inflammatory pathways in fetal astrocytes and brain microvascular endothelial cells exposed to hemoglobin isoforms. Notably, interleukin-1B (IL1B) is upregulated following RBCL and hemorrhagic CSF exposure. To probe its role, this work applies an IL1 receptor antagonist, which demonstrate that IL1B has a partially protective influence on neurogenesis. These findings highlight the SVZ-on-a-chip as a powerful tool for studying IVH pathology and emphasize the role of inflammation in regulating neurogenesis. IL1B emerges as a potential therapeutic target, offering new avenues for intervention. This study advances the understanding of IVH and lays the groundwork for developing strategies to protect the developing brain.

Indexed as

Cerebral HemorrhageCerebral Intraventricular HemorrhageLab-On-A-Chip DevicesLateral VentriclesNeurogenesisHumansInfant, NewbornInfant, PrematureInterleukin-1betaIL1B protein, humanInterleukin-1betacerebrospinal fluidinflammationinterleukin‐1bintraventricular hemorrhageneurogenesisorgan‐on‐a‐chipsubventricular zone

Identifiers

PMID41133939
PMCPMC12806495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.